West Nile Virus Vaccine Under Development
Posted on: Tuesday, 4 November 2008, 09:00 CST
German scientists say they are developing a DNA-based West Nile virus vaccine that can also be effective after onset of the disease.
The researchers at the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig said in their vaccine DNA molecules known as plasmids are extracted from the pathogen and are used for inoculation, instead of the whole virus.
"They contain the genetic code for the antigens that stimulate the body to produce antibodies," said Matthias Giese, who is leading the vaccine development. "We can thus replicate the virus's natural infection route without actually triggering the disease."
Such vaccines, he said, are inexpensive and do not require refrigeration, which makes them ideal for use in subtropical and tropical climates. And unlike conventional vaccines, DNA vaccines can be used both prophylactically and therapeutically.
Giese expects the laboratory research to be completed by the end of 2009. After that, at least another three years will be needed for clinical trials and regulatory approval.
Then, he said, it is hoped, the world's first therapeutic West Nile virus vaccine will be ready for market.
Source: United Press International
Related Articles
- Hepatitis C Virus DNA Vaccine Shows Safety When Delivered By Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital
- CytoGenix Announces Agreement With Taiwan Cobia Inc. To Develop DNA Vaccines for Fish Viruses
- Single Injection of Vical's Avian Flu DNA Vaccine Provides 100% Protection in Ferrets
- Vical's DNA Vaccine With Vaxfectin(TM) Adjuvant Advances in Pandemic Influenza Program
- Vical Initiates Trial of DNA Vaccine
- Vical Opens Phase 2 Trial of DNA Vaccine Against CMV
- In a crisis, creating DNA vaccine could help save lives, slow spread of 'bird flu'
- CDC, Fort Dodge Animal Health Achieve First Licensed DNA Vaccine
- Developing DNA Vaccines That Call to Dendritic Cells
- DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response
User Comments (0)

RSS Feeds